Pricing and reimbursement of generic pharmaceuticals in Turkey: Evaluation of hypertension drugs from 2007 to 2013

Basit Öğe Kaydı
dc.authorid0000-0001-7083-1377
dc.contributor.authorKumru, Seda
dc.contributor.authorTop, Mehmet
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T19:50:30Z
dc.date.available10.07.201910:49:13
dc.date.available2019-07-10T19:50:30Z
dc.date.issued2018
dc.departmentİstanbul Medipol Üniversitesi, Sağlık Bilimleri Fakültesi, Sağlık Yönetimi Bölümü
dc.descriptionWOS: 000436912800012
dc.description.abstractPurpose: This study was designed to examine the effects of drug pricing and reimbursement politics on drug expenditures from January 2007 to September 2013, with a focus on internal reference pricing in Turkey. Method: Data used in this study are from January 2007 to September 2013, which includes five drug clusters involving original drugs and the first generic drug (equivalent of the original drug) that was available on the market in 2010 and 2011. The effect of the first generic drug that entered the market on original drug use was analyzed using the time-series analysis method. To account for the absence of generic drugs in the market, original drug consumption was estimated and compared with original drug consumption following generic drug entry. Winters' Additive was selected as the most suitable method to estimate the consumption amount of the original drug in the five equivalent groups. Results: From 2007 to 2012, the consumption of prescribed drugs in the hypertension group increased about 63% and hypertension drug expenditures of the Social Security Institute (SSI) increased almost 82%. Between 2007 and 2012, the increase in hypertension drug consumption not included in the equivalent group was 83%, whereas it was calculated as 61% for drugs in the equivalent group. The prices of the original and generic drugs were similar as time went by and after regulation by authorities. Conclusion: The generic drug market in Turkey has not reached its full potential. Original pharmaceuticals still dominate most of the market. The internal reference pricing system in Turkey has not been able to encourage price competitiveness and price reductions.
dc.description.sponsorshipScientific and Technological Research Council of Turkey Direct Institute Doctorate Scholarship Program [1649B031000021]en_US
dc.description.sponsorshipThe data used in this study was obtained from the doctorate thesis study entitled "Effects of Reimbursement Reference Pricing in Hypertension Pharmaceutical Expenditure: 2007-2012 Period Evaluation". This thesis was supported by The Scientific and Technological Research Council of Turkey Direct Institute Doctorate Scholarship Program (Grant no. 1649B031000021) (TUBITAK Dogrudan Yurt Ici Doktora Burs Programs). Thesis detail: "Effects of Reimbursement Reference Pricing in Hypertension Pharmaceutical Expenditure: 2007-2012 Period Evaluation". Doctoral Thesis, Hacettepe University, Social Sciences Institute, Ankara, Turkey, 2015.en_US
dc.identifier.citationKumru, S. ve Top, M. (2018). Pricing and reimbursement of generic pharmaceuticals in Turkey: Evaluation of hypertension drugs from 2007 to 2013. Health Policy and Technology, 7(2), 182-193. https://dx.doi.org/10.1016/j.hlpt.2018.03.004
dc.identifier.doi10.1016/j.hlpt.2018.03.004
dc.identifier.endpage193
dc.identifier.issn2211-8837
dc.identifier.issue2
dc.identifier.scopusqualityQ3
dc.identifier.startpage182
dc.identifier.urihttps://dx.doi.org/10.1016/j.hlpt.2018.03.004
dc.identifier.urihttps://hdl.handle.net/20.500.12511/2003
dc.identifier.volume7
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherElsevier Sci Ltd
dc.relation.ispartofHealth Policy and Technologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectPharmacoeconomics
dc.subjectHealth Economics
dc.subjectGeneric Drugs
dc.subjectGeneric Pharmaceutical Pricing
dc.subjectReimbursement
dc.subjectInternal Reference Pricing
dc.titlePricing and reimbursement of generic pharmaceuticals in Turkey: Evaluation of hypertension drugs from 2007 to 2013
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Kumru, S..pdf
Boyut:
1.81 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu